Prevention of Docetaxel Induced Dacryostenosis
NCT00266838
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Epiphora
Interventions
DRUG:
Maxidex; Lacrystat
Sponsor
Universitaire Ziekenhuizen KU Leuven